JAMA

January 24, 2024

Long-term follow-up pinpoints side effects of treatments for prostate cancer patients

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

By Craig Boerner
October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner
August 28, 2023

Study on miscarriage management finds combination treatment is more efficient and cost effective

Vanderbilt research finds that only 1% of 22,116 commercially insured women ages 15-49 with medically managed miscarriages received the recommended combination of mifepristone.

By Danny Bonvissuto
Wesley Self, MD, MPH
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.

By Nancy Humphrey
January 12, 2023

Clinical trial compares different therapies for spine pain

A Vanderbilt clinical trial to determine whether multidisciplinary biopsychosocial intervention or individualized postural therapy intervention improved disability and reduced health care spending in patients with acute or subacute spine pain.

By Danny Bonvissuto
doctor checking patient's blood pressure
June 20, 2022

Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk

Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.

By Nancy Humphrey
December 21, 2021

Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

By Jill Clendening
December 15, 2021

Study finds similar success rates with two devices for breathing tube placement

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.
By Leigh MacMillan
July 15, 2021

Study shows continuous glucose monitors improve management of type 2 diabetes

For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.
By Jill Clendening
March 18, 2021

Strength training for osteoarthritis

High-intensity strength training is not more effective than low-intensity training or educational efforts for reducing knee pain in patients with osteoarthritis.
By Emily Stembridge
January 12, 2021

Study shows drastic increases in opioid-affected births

The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.
By Craig Boerner
December 3, 2020

JAMA Health Forum to become full-fledged journal in 2021

Just a year after its founding as an online channel of information, the Journal of the American Medical Association’s (JAMA’s) Health Forum will become a full-fledged journal in January 2021.
By Jake Lowary
November 9, 2020

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
By Bill Snyder